Severity
Low
FDA Devices recall · Reported January 12, 2022
The dosage information on the pouch is incorrect; the primary carton label is correct.
Tapemark Company recalled iontoPATCH On-the-Go Patch Therapy, Transdermal Iontophoretic Drug Delivery System, Extr… - a low-severity action.
iontoPATCH On-the-Go Patch Therapy, Transdermal Iontophoretic Drug Delivery System, Extr… was recalled by Tapemark Company in January 12, 2022. Reason: The dosage information on the pouch is incorrect; the primary carton label is correct.. Check the official notice for the remedy. Verify recall #Z-0454-2022 with the FDA Devices before acting.
The recall
Tapemark Company issued this low-severity FDA Devices recall-The dosage information on the pouch is incorrect; the primary carton label is correct..
Sourced from official FDA Devices enforcement records. Verify recall #Z-0454-2022 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Devices action (record #Z-0454-2022) was formally reported on January 12, 2022, with the manufacturer initiating the action on November 10, 2021. It is classified under Low severity (Class III), with a current status of Terminated. Tapemark Company is listed as the recalling firm, operating out of Saint Paul, MN. Federal records list the affected scope as 5,141 primary cartons.
The documented reason for this recall is: The dosage information on the pouch is incorrect; the primary carton label is correct. Distribution data in the federal record shows the product reached: US Nationwide distribution in the states of CA, FL, IL, MO, NY, OH, and TN.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,861 medical devices recalls on record
Of 88,001 recalls with an agency hazard classification, 19,020 are high severity, 64,468 moderate, and 4,513 low. A further 16,157 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
5,141 primary cartons
Related Recalls
6
6 from same agency
iontoPATCH On-the-Go Patch Therapy, Transdermal Iontophoretic Drug Delivery System, Extra Strength, 8-HOUR Average Wear Time, 6/1-patch pouches/box. Dosage: 120mA/min.
The dosage information on the pouch is incorrect; the primary carton label is correct.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | Z-0454-2022 |
| Date reported | January 12, 2022 |
| Date initiated | November 10, 2021 |
| Recalling firm | Tapemark Company |
| Firm location | Saint Paul, MN |
| Affected scope | 5,141 primary cartons |
| Distribution | US Nationwide distribution in the states of CA, FL, IL, MO, NY, OH, and TN. |
Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
Boston Scientific Corporation · 2026-07-29
Boston Scientific Corporation · 2026-07-29
AVID Medical, Inc. · 2026-07-29
Penumbra, Inc. · 2026-07-29
Alphatec Spine, Inc. · 2026-07-29
Compare this recall with FARADRIVE STEERABLE SHEATH CLEAR, used to facilitate access… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Devices, reported January 12, 2022. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.